our solutions

We aim to develop a product line that is robust and widely used as the clinical standard for CTC enrichment, and enumeration

Key advantages


Single Step

Our technology allows the gentle isolation of CTC directly from fresh whole blood with no pre-processing steps involved to provide unaltered high-quality capture material.

see product catalog

Adaptable Technology

Easy-to-handle devices for immediate compatibility with downstream characterization and analysis techniques. The capture devices are modular and can be manufactured from a wide range of materials to adjust to end-user application.



Our technology is evolutive. We are currently developing connected systems for real-time transmission of data to accelerate clinical decision-making.


End user :

Our research use clientele are made up of academic labs and institutions, CROs, and pharmaceutical industry.

CTC-Station isolates CTC in a few minutes from fresh blood samples without pre-treatment

CTC-STATION© is a fully-automatized benchtop system reproducing in vivo conditions to ensure optimal capture of CTC from blood samples for subsequent analysis.

CTC-STATION© will be deployed into academic research centers, clinical research institutes, and pharmaceutical industries to accelerate the adoption process of our technology into well-established CTC workflows, limited to research purposes.


End user :

•Clinics•Oncology centers

Portable clinically fitted system

CTC-PHERESIS provides the clinician a solution for the continuous, high-volume, and direct capture of cancer cells in blood. This innovation is conceived to fit an aphaeretic device able to screen a maximum volume of patient blood directly from a peripheral vein. The large blood volume in combination with the highly specific capture devices, could lead to increased cancer cells counts and better representativeness. Facing the inadequacy of current approaches with clinical routine, CTC-PHERESIS system is designed to be portable, and compatible with standard blood-processing medical devices and consumables.

Key benefits are:

  • Quick access to high quality information to provide the right treatment at the right time
  • Access to tumoral material in a more systematic and frequent manner to evaluate treatment efficiency
  • Acceleration of decision-making to screen more patients at earlier stages and improve patient care
  • Standardize patient selection for treatments
  • Simplification of practices and reduction of costs in healthcare

Looking for a mild technique for CTC capture?

Reach out to us !
We develop solutions that meet your needs.

Contact us